Filed: 10/21/2026ACC: 0001951757-26-001733
📋 What this filing means
PSP RESEARCH LLC filed this quarterly 13F‑HR report disclosing 44 equity positions with a total reported market value of $145.83M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
44
Positions
$145.83M
Total AUM (reported)
3.81M
Total Shares
Allocation by class
0-3 MTH TREASURY$70.48M48.3%
ST STR SP BIOT$60.94M41.8%
COM$7.51M5.1%
CLASS A COM$5.01M3.4%
SHS CLASS A$291.8K0.2%
SPONSORED ADR$287.7K0.2%
ORD SHS CL A$261.1K0.2%
Portfolio Concentration
Top 3$136.43M93.6%
4–10$2.07M1.4%
11–25$3.81M2.6%
Rest$3.52M2.4%
Top 3 weight
93.6%
Top 10 weight
95.0%
Voting Authority Distribution
Total shares with voting rights: 3.81M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
3.81M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole44
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings44
Rows:
ISHARES TR
SOLEShares700K
TypeSH
Market value$70.48M
48.33%
Sole
0.00
Shared
0.00
None
700K
SPDR SERIES TRUST
SOLEShares386.50K
TypeSH
Market value$60.94M
41.79%
Sole
0.00
Shared
0.00
None
386.50K
SERA PROGNOSTICS INC
SOLEShares2.40M
TypeSH
Market value$5.01M
3.43%
Sole
0.00
Shared
0.00
None
2.40M
HALOZYME THERAPEUTICS INC
SOLEShares3K
TypeSH
Market value$331.2K
0.23%
Sole
0.00
Shared
0.00
None
3K
MADRIGAL PHARMACEUTICALS INC
SOLEShares600.00
TypeSH
Market value$302.4K
0.21%
Sole
0.00
Shared
0.00
None
600.00
EXELIXIS INC
SOLEShares5K
TypeSH
Market value$292.1K
0.20%
Sole
0.00
Shared
0.00
None
5K
ROYALTY PHARMA PLC
SOLEShares5K
TypeSH
Market value$291.8K
0.20%
Sole
0.00
Shared
0.00
None
5K
ARGENX SE
SOLEShares300.00
TypeSH
Market value$287.7K
0.20%
Sole
0.00
Shared
0.00
None
300.00
NURIX THERAPEUTICS INC
SOLEShares12K
TypeSH
Market value$284.5K
0.20%
Sole
0.00
Shared
0.00
None
12K
TG THERAPEUTICS INC
SOLEShares5K
TypeSH
Market value$278.9K
0.19%
Sole
0.00
Shared
0.00
None
5K
TARSUS PHARMACEUTICALS INC
SOLEShares3.50K
TypeSH
Market value$275.1K
0.19%
Sole
0.00
Shared
0.00
None
3.50K
HARMONY BIOSCIENCES HLDGS IN
SOLEShares7K
TypeSH
Market value$274.8K
0.19%
Sole
0.00
Shared
0.00
None
7K
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares10K
TypeSH
Market value$264.3K
0.18%
Sole
0.00
Shared
0.00
None
10K
KINIKSA PHARMACEUTICALS INTL
SOLEShares3.50K
TypeSH
Market value$261.1K
0.18%
Sole
0.00
Shared
0.00
None
3.50K
SUPERNUS PHARMACEUTICALS
SOLEShares6K
TypeSH
Market value$258.2K
0.18%
Sole
0.00
Shared
0.00
None
6K
IMMUNOME INC
SOLEShares12K
TypeSH
Market value$258.1K
0.18%
Sole
0.00
Shared
0.00
None
12K
NEUROCRINE BIOSCIENCES INC
SOLEShares1.80K
TypeSH
Market value$255.3K
0.18%
Sole
0.00
Shared
0.00
None
1.80K
ORUKA THERAPEUTICS INC
SOLEShares3K
TypeSH
Market value$249.9K
0.17%
Sole
0.00
Shared
0.00
None
3K
TANGO THERAPEUTICS INC
SOLEShares10K
TypeSH
Market value$249.5K
0.17%
Sole
0.00
Shared
0.00
None
10K
DEFINIUM THERAPEUTICS INC
SOLEShares6.50K
TypeSH
Market value$247.4K
0.17%
Sole
0.00
Shared
0.00
None
6.50K
REVOLUTION MEDICINES INC
SOLEShares1.20K
TypeSH
Market value$246.3K
0.17%
Sole
0.00
Shared
0.00
None
1.20K
ALKERMES PLC
SOLEShares6K
TypeSH
Market value$243.1K
0.17%
Sole
0.00
Shared
0.00
None
6K
AURINIA PHARMACEUTICALS INC
SOLEShares15K
TypeSH
Market value$242.9K
0.17%
Sole
0.00
Shared
0.00
None
15K
INCYTE CORP
SOLEShares2K
TypeSH
Market value$242.7K
0.17%
Sole
0.00
Shared
0.00
None
2K
INTELLIA THERAPEUTICS INC
SOLEShares20K
TypeSH
Market value$241.2K
0.17%
Sole
0.00
Shared
0.00
None
20K
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ISHARES TRSOLE | 0-3 MTH TREASURY | 700K | SH | $70.48M 48.33% | 0.00 | 0.00 | 700K |
SPDR SERIES TRUSTSOLE | ST STR SP BIOT | 386.50K | SH | $60.94M 41.79% | 0.00 | 0.00 | 386.50K |
SERA PROGNOSTICS INCSOLE | CLASS A COM | 2.40M | SH | $5.01M 3.43% | 0.00 | 0.00 | 2.40M |
HALOZYME THERAPEUTICS INCSOLE | COM | 3K | SH | $331.2K 0.23% | 0.00 | 0.00 | 3K |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 600.00 | SH | $302.4K 0.21% | 0.00 | 0.00 | 600.00 |
EXELIXIS INCSOLE | COM | 5K | SH | $292.1K 0.20% | 0.00 | 0.00 | 5K |
ROYALTY PHARMA PLCSOLE | SHS CLASS A | 5K | SH | $291.8K 0.20% | 0.00 | 0.00 | 5K |
ARGENX SESOLE | SPONSORED ADR | 300.00 | SH | $287.7K 0.20% | 0.00 | 0.00 | 300.00 |
NURIX THERAPEUTICS INCSOLE | COM | 12K | SH | $284.5K 0.20% | 0.00 | 0.00 | 12K |
TG THERAPEUTICS INCSOLE | COM | 5K | SH | $278.9K 0.19% | 0.00 | 0.00 | 5K |
TARSUS PHARMACEUTICALS INCSOLE | COM | 3.50K | SH | $275.1K 0.19% | 0.00 | 0.00 | 3.50K |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 7K | SH | $274.8K 0.19% | 0.00 | 0.00 | 7K |
ARCUTIS BIOTHERAPEUTICS INCSOLE | COM | 10K | SH | $264.3K 0.18% | 0.00 | 0.00 | 10K |
KINIKSA PHARMACEUTICALS INTLSOLE | ORD SHS CL A | 3.50K | SH | $261.1K 0.18% | 0.00 | 0.00 | 3.50K |
SUPERNUS PHARMACEUTICALSSOLE | COM | 6K | SH | $258.2K 0.18% | 0.00 | 0.00 | 6K |
IMMUNOME INCSOLE | COM | 12K | SH | $258.1K 0.18% | 0.00 | 0.00 | 12K |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 1.80K | SH | $255.3K 0.18% | 0.00 | 0.00 | 1.80K |
ORUKA THERAPEUTICS INCSOLE | COM | 3K | SH | $249.9K 0.17% | 0.00 | 0.00 | 3K |
TANGO THERAPEUTICS INCSOLE | COM | 10K | SH | $249.5K 0.17% | 0.00 | 0.00 | 10K |
DEFINIUM THERAPEUTICS INCSOLE | COM SHS | 6.50K | SH | $247.4K 0.17% | 0.00 | 0.00 | 6.50K |
REVOLUTION MEDICINES INCSOLE | COM | 1.20K | SH | $246.3K 0.17% | 0.00 | 0.00 | 1.20K |
ALKERMES PLCSOLE | SHS | 6K | SH | $243.1K 0.17% | 0.00 | 0.00 | 6K |
AURINIA PHARMACEUTICALS INCSOLE | COM | 15K | SH | $242.9K 0.17% | 0.00 | 0.00 | 15K |
INCYTE CORPSOLE | COM | 2K | SH | $242.7K 0.17% | 0.00 | 0.00 | 2K |
INTELLIA THERAPEUTICS INCSOLE | COM | 20K | SH | $241.2K 0.17% | 0.00 | 0.00 | 20K |
Page 1 of 2